Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · Real-Time Price · USD

7.24

+0.21 (2.99%)

At close: Apr 28, 2026, 4:00 PM EDT

7.24

0.00 (0.00%)

After-hours: Apr 28, 2026, 4:11 PM EDT

Relmada Therapeutics Employees

Relmada Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year.

Employees

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

n/a

Profits / Employee

-$3,375,598

Market Cap

759.39M

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2025	17	0	-
Dec 31, 2024	17	-3	-15.00%
Dec 31, 2023	20	6	42.86%
Dec 31, 2022	14	4	40.00%
Dec 31, 2021	10	-4	-28.57%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro

Company Name	Employees
Allogene Therapeutics	152
Solid Biosciences	121
Alpha Tau Medical	121
Cullinan Therapeutics	109
BridgeBio Oncology Therapeutics	92
Lexicon Pharmaceuticals	81
Vor Biopharma	76
Design Therapeutics	54